Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

FDA clears new Tilade formulation

Nov. 18, 1997

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

FACET study demonstrates improved asthma control with Pulmicort and Oxis

Nov. 17, 1997

Novartis claims new antiasthmatic agents

Nov. 17, 1997

Pfizer describes new PDE IV inhibitor for asthma

Nov. 14, 1997

First interim phase III safety results reported for OxSODrol

Nov. 14, 1997

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Nov. 13, 1997

New 5-LO inhibitors from Meiji Milk

Nov. 13, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...